EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Effects of Imatinib on Glucose-6-phosphate Dehydrogenase and Glutathione Reductase

B Tandogan, C Sengezer, N N Ulusu

Folia Biologica · 2011 · 57 (2) · 57-64

DOI: 10.14712/fb2011057020057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Biologica, online erschienen am 12.09.2024. Verfasst von B Tandogan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hacettepe University, Department of Biochemistry, Ankara, Turkey. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hacettepe Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imatinib (Gleevec, STI571) is a drug used to treat certain types of cancer. Glucose-6-phosphate dehydrogenase and glutathione reductase are enzymes important for redox homeostasis and play key roles in many cellular processes. The purpose of the present work is to evaluate the in vitro effects of imatinib on sheep brain cortex glucose-6-phosphate dehydrogenase, and on bovine kidney cortex, bovine liver and yeast glutathione reductase. Kinetic studies on the inhibition of enzymes by imatinib have been investigated by using Lineweaver-Burk double reciprocal plot and values summarized with graphs by plotting the data using Linewear-Burk diagrams of 1/v against 1/[S] at each [ I ]. Imatinib inhibits glucose-6-phosphate dehydrogenase with an IC 50 value of 0.7 mM. It inhibits bovine kidney cortex, liver and yeast glutathione reductase in a concentration-dependent manner with IC 50 values of 0.8, 0.92, 1 mM, respectively. We have investigated the kinetic characteristics, inhibition types and constants (Ki). Inhibition of the glucose-6-phosphate dehydrogenase and glutathione reductase represents an attractive approach to the development of anticancer agents. This study shows the molecular effectiveness of the drug on purified enzymes of various sources. Understanding the kinetic mechanism of the drug and enzyme relationship may be a powerful approach to the future drug studies concerning new cancer drugs, drug resistance and new aspects in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntineoplastic AgentsBenzamidesCattleGlucosephosphate DehydrogenaseGlutathione ReductaseImatinib MesylateKineticsPiperazinesPyrimidinesSaccharomyces cerevisiaeSheep

Substanzen

Antineoplastic AgentsBenzamidesPiperazinesPyrimidinesImatinib MesylateGlucosephosphate DehydrogenaseGlutathione Reductase

Autor:innen und Institutionen

  • Hacettepe University, Department of Biochemistry, Ankara, Turkey.

Förderung

  • Hacettepe Üniversitesi

Zitieren

APA

Tandogan, B., Sengezer, C., & Ulusu, N. N. (2011). In Vitro Effects of Imatinib on Glucose-6-phosphate Dehydrogenase and Glutathione Reductase. Folia Biologica, 57(2), 57-64. https://doi.org/10.14712/fb2011057020057

Vancouver

Tandogan B, Sengezer C, Ulusu NN. In Vitro Effects of Imatinib on Glucose-6-phosphate Dehydrogenase and Glutathione Reductase. Folia Biologica. 2011;57(2):57-64. doi:10.14712/fb2011057020057

BibTeX
@article{Tandogan2011,
  author = {Tandogan, B and Sengezer, C and Ulusu, N N},
  title = {In Vitro Effects of Imatinib on Glucose-6-phosphate Dehydrogenase and Glutathione Reductase},
  journal = {Folia Biologica},
  year = {2011},
  volume = {57},
  number = {2},
  pages = {57--64},
  doi = {10.14712/fb2011057020057}
}
Kostenlos starten →